mbiomics

Munich, Germany

mbiomics is a biotechnology company.

$14.1M raised

Apr 2026

Series A

Top Investors

HTGF (High-Tech Gruenderfonds)Bayern KapitalMIG FondsMIG Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has mbiomics raised?

mbiomics has raised $14.1M in total funding. The most recent round was Series A. The last funding was announced in April 2026.

Who are mbiomics's investors?

mbiomics's investors include HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Fonds, MIG Capital.

Where is mbiomics headquartered?

mbiomics is headquartered in Munich, Germany.

What does mbiomics do?

mbiomics is a biotechnology company.

What stage is mbiomics at?

mbiomics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2026.

MLA

"mbiomics — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/mbiomics. Accessed June 4, 2026.

APA

VCBacked. (2026). mbiomics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mbiomics

Wikipedia (cite web)

{{cite web |title=mbiomics — Funding & Investors |url=https://www.vcbacked.co/company/mbiomics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2026.